Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk
抗癌药公司百济神州主动应变，降低退市风险

Company has changed auditors in a bid to comply with U.S. law and avoid a potential forced delisting from the Nasdaq
该公司更换了审计机构，以遵守美国法律，避免在纳斯达克被强制退市